RESUMEN
Prolonged air leak after a lung volume reduction operation for pulmonary emphysema is a major cause of morbidity and prolonged hospital stay. Staple line reinforcement is recognized as an effective adjunctive technique for decreasing the occurrence of air leaks after pulmonary wedge resection. Numerous materials have been used for staple-line reinforcement. We use expanded polytetrafluoroethylene sleeves that fit over the arms of surgical staplers to facilitate staple-line reinforcement in both thoracoscopic and open lung volume reduction procedures. The expanded polytetrafluoroethylene sleeves do not require rinsing or special handling; they are easy to use and effective in preventing air leaks. We had no prolonged air leaks or infections in any of the cases in which we used the sleeves.
Asunto(s)
Neumonectomía , Politetrafluoroetileno , Complicaciones Posoperatorias/prevención & control , Enfisema Pulmonar/cirugía , Grapado Quirúrgico/métodos , Humanos , Engrapadoras QuirúrgicasRESUMEN
The subtle human health effects from prolonged exposure to small amounts of mercury vapor are unknown. It has been difficult to study possible effects of low-dose exposure for lack of a good measure of long-term exposure. Current methods which use blood, urine, hair, and nails reliably measure only recent exposures. Long-term exposure to lead has been measured using levels found in human dentin. The purpose of this study was to determine whether mercury also accumulates in dentin. In this study, dentin from 16 human teeth, all without dental amalgam restorations, was analyzed by thermal neutron activation analysis. The teeth were selected from people with and without dental mercury amalgam restorations elsewhere in their dentitions. Mercury was found in amounts up to 5.9 ppm. While the highest mercury level was from a sample from someone who had dental amalgam restorations elsewhere in their dentition, the second highest was from someone who had no amalgam restorations. Also, a sample which was not used for any statistical comparisons but which was analyzed because the tooth contained an amalgam restoration had one of the lowest levels of mercury. These results, while inconclusive due to a small sample size, suggest that inorganic mercury vapor is a relatively small contributor to the overall body burden of mercury.
Asunto(s)
Amalgama Dental , Dentina/química , Mercurio/análisis , Diente/química , Adolescente , Adulto , HumanosAsunto(s)
Consultorios Odontológicos , Enfermedades Profesionales/prevención & control , Aerosoles , Control de Enfermedades Transmisibles/métodos , Amalgama Dental , Dermatitis Profesional/prevención & control , Humanos , Ruido en el Ambiente de Trabajo , Exposición Profesional , Postura , Protección RadiológicaAsunto(s)
Materiales Dentales , Restauración Dental Permanente/instrumentación , Resinas Acrílicas , Materiales Biocompatibles , Caries Dental/terapia , Historia de la Odontología , Historia del Siglo XVI , Historia del Siglo XVII , Historia del Siglo XVIII , Historia del Siglo XIX , Historia Antigua , Historia Medieval , Humanos , PolímerosRESUMEN
Bilateral ureteral ligation changes the blood urea nitrogen (BUN) concentration in pregnant and non-pregnant rats. Marked increases of the BUN concentration occurred in both pregnant and non-pregnant specimens after ligation. The BUN concentration in sham-ligated rats did not change from day 16 through 19 of pregnancy, but increased on day 20 of pregnancy and thereafter. There was no significant difference in BUN between ligated pregnant rats on days 16 and 17 of pregnancy and ligated non-pregnant rats. As pregnancy progressed from day 18 onward, the BUN in ligated pregnant rats decreased when compared with that of ligated non-pregnant rats, but did not reach the level in sham-ligated pregnant rats. The BUN of mothers and fetuses both in the ligated and the sham-ligated groups were similar. Amniotic fluid urea nitrogen levels were higher than in blood on late fetal days. In ligated mothers, a significant relationship between maternal BUN and the number of fetuses was noted on day 22 of pregnancy. These results suggest that the fetal kidney becomes functional for excreting urea in late fetal life.
Asunto(s)
Nitrógeno de la Urea Sanguínea , Complicaciones del Embarazo/sangre , Uremia/complicaciones , Líquido Amniótico/metabolismo , Animales , Femenino , Feto/metabolismo , Riñón/fisiopatología , Ligadura , Tamaño de la Camada , Embarazo , Complicaciones del Embarazo/fisiopatología , Ratas , Ratas Endogámicas , Urea/metabolismo , Uremia/fisiopatología , UréterRESUMEN
We have conducted a Phase I and initial clinical pharmacological evaluation of 4'-deoxydoxorubicin (4'-DXDX), administering the drug i.v. on an every 21-day schedule to 60 patients with advanced cancer. Patients were treated at six dosage levels ranging from 10 to 35 mg/sq m. Leukopenia was the dose-limiting toxic effect, and no cardiac, renal, or hepatic toxicity was observed; stomatitis was not seen; and there were no drug-related deaths. Significant alopecia was rare at doses less than 35 mg/sq m, mild nausea and vomiting occurred in one-third of patients at myelosuppressive doses; 12 patients had a transient local urticarial reaction. In the 30 patients with measurable disease, two partial remissions were seen, lasting 5 months in a patient with a nasopharyngeal adenocarcinoma, and 7 months in a patient with endometrial adenocarcinoma. The recommended dose of 4'-DXDX for Phase II studies is 30 mg/sq m in good-risk patients and 25 mg/sq m in moderate-risk or heavily pretreated patients. Pharmacokinetic studies were carried out in ten patients, four of whom received 4'-DXDX at a dose of 10 mg/sq m and six at 30 mg/sq m. Disappearance of 4'-DXDX from plasma was triphasic with a rapid initial phase clearance showing a t1/2 alpha of 1 to 2 min and a prolonged terminal phase with a median t1/2 gamma in excess of 90 h in patients receiving 30 mg/sq m.
Asunto(s)
Antineoplásicos/uso terapéutico , Doxorrubicina/análogos & derivados , Neoplasias/tratamiento farmacológico , Adulto , Anciano , Antineoplásicos/efectos adversos , Antineoplásicos/metabolismo , Doxorrubicina/efectos adversos , Doxorrubicina/metabolismo , Doxorrubicina/uso terapéutico , Evaluación de Medicamentos , Femenino , Corazón/efectos de los fármacos , Humanos , Cinética , Masculino , Persona de Mediana EdadRESUMEN
Fifty-two adults treated previously with either acute leukemia (43 patients) or blastic-phase chronic myelogenous leukemia (nine patients) received 4-demethoxydaunorubicin (20 to 45 mg/sq m) i.v. over 2 to 3 days. Three of the ten patients with acute lymphocytic leukemia achieved a complete remission (CR) lasting 5 to 7 weeks. Five of the 28 patients with acute nonlymphocytic leukemia achieved a CR lasting 5 to 80 weeks. All remissions were induced with one course of treatment with a median time to CR of 28 days (range, 22 to 40 days). None of the patients with blastic chronic myelogenous leukemia or secondary leukemia achieved a CR. The drug was well tolerated; mucositis (36%), nausea and vomiting (35%), and hepatic dysfunction (26%) were the most common side effects. Pharmacokinetic observations on five patients demonstrated multiphasic clearance of 4-demethoxydaunorubicin and extensive formation and prolonged retention of 4-demethoxy-13-hydroxydaunorubicin; that metabolite accumulated in plasma on repeated daily dosing. 4-Demethoxydaunorubicin has sufficient antileukemic activity in both acute lymphocytic leukemia and acute nonlymphocytic leukemia to warrant a prospective comparison, in combination regimens, against the conventional anthracyclines, daunorubicin and/or doxorubicin.
Asunto(s)
Antineoplásicos/uso terapéutico , Daunorrubicina/análogos & derivados , Leucemia/tratamiento farmacológico , Enfermedad Aguda , Adolescente , Adulto , Anciano , Daunorrubicina/efectos adversos , Daunorrubicina/metabolismo , Daunorrubicina/uso terapéutico , Evaluación de Medicamentos , Femenino , Humanos , Idarrubicina , Cinética , Masculino , Persona de Mediana EdadRESUMEN
Sequential specular microscopy has shown that coalescence of endothelial cells occurs after thawing in cryopreserved rabbit corneas. Scanning electron microscopy of corneas studied in vitro by specular microscopy showed the same large, fused endothelial cells. As observed in the electron micrographs, these cells showed no evidence of the cell borders that had disappeared during the specular microscopic examination. These data support the reliability of our specular microscopic observations and provide additional evidence for the occurrence of fusion or coalescence of corneal endothelial cells.
Asunto(s)
Fusión Celular , Córnea/citología , Animales , Córnea/ultraestructura , Endotelio/citología , Endotelio/ultraestructura , Congelación , Microscopía , Microscopía Electrónica de Rastreo , ConejosRESUMEN
4-Demethoxydaunorubicin (4-DMDR), an anthracycline analogue available in i.v. and p.o. form, has shown significant antitumor activity in murine tumor models while producing less cardiac toxicity than doxorubicin at equimyelotoxic doses. Phase I and clinical pharmacology studies of the i.v. and p.o. preparation were performed. With i.v. 4-DMDR, consistent myelosuppression was observed at a dose of 15 mg/sq m at a median Day 15; mild nausea and vomiting were observed in 9% of all treatment courses. In patients given p.o. 4-DMDR, myelosuppression occurred at median Day 14 in 10 of 12 patients given 50 mg/sq m. Nausea and vomiting occurred in 25% of all treatment courses, and dividing the dose over 3 days did not decrease the incidence. Alopecia occurred in 13% of evaluable patients treated with the i.v. preparation and 30% of evaluable patients treated p.o. No stomatitis was observed with either preparation, and no patient developed clinical signs of congestive heart failure. Pharmacokinetic studies were performed with both preparations and revealed prolonged plasma levels of the 13-hydroxy metabolite 4-DMDR-ol. The suggested starting dose for Phase II studies is 12.5 mg/sq m given every 21 days for i.v. 4-DMDR with dose escalation by 2.5 mg/sq m in the absence of myelotoxicity. For p.o. 4-DMDR, the suggested starting dose is 40 mg/sq m given every 21 days with escalation by 10 mg/sq m if no myelotoxicity is observed.
Asunto(s)
Antineoplásicos/toxicidad , Daunorrubicina/análogos & derivados , Neoplasias/tratamiento farmacológico , Administración Oral , Adulto , Anciano , Daunorrubicina/administración & dosificación , Daunorrubicina/sangre , Daunorrubicina/toxicidad , Evaluación de Medicamentos , Femenino , Humanos , Idarrubicina , Terapia de Inmunosupresión , Inyecciones Intravenosas , Cinética , Masculino , Persona de Mediana EdadRESUMEN
Stuttering and aphasia emerged as salient clinical features in an adult with multifocal brain damage and paroxysmal EEG activity. Anticonvulsant treatment was associated with reversal of the stuttering and with marked improvement in language abilities.
Asunto(s)
Fenobarbital/uso terapéutico , Fenitoína/uso terapéutico , Tartamudeo/tratamiento farmacológico , Adulto , Lesiones Encefálicas/complicaciones , Carbamazepina/uso terapéutico , Quimioterapia Combinada , Epilepsia Postraumática/tratamiento farmacológico , Femenino , HumanosRESUMEN
Acidic proline-rich proteins were localized histologically by means of the indirect immunoperoxidase technique in the acinar cells of parotid and submandibular gland sections of both man and Macaca fascicularis. These proteins were also identified as constituents of the long term in vivo-formed acquired pellicle on human tooth surfaces employing the same immunoperoxidase technique. Immunological quantitation of proline-rich proteins in whole and parotid saliva of 42 subjects indicates the presence of high concentrations in parotid secretions varying between 19-80 mg%, while their levels in whole saliva are significantly lower, ranging between 0-18 mg%. The concentrations of these proteins in whole saliva exhibited a negative correlation with plaque accumulation (r = -0.464) and gingival index scores (r = -0.576).
Asunto(s)
Depósitos Dentarios/análisis , Glándula Parótida/análisis , Péptidos/análisis , Prolina/análisis , Proteínas y Péptidos Salivales/análisis , Glándula Submandibular/análisis , Animales , Antígenos/análisis , Esmalte Dental/análisis , Película Dental , Haplorrinos , Humanos , Inmunodifusión , Técnicas para Inmunoenzimas , Macaca fascicularis , Prolina/inmunología , Dominios Proteicos Ricos en ProlinaRESUMEN
Epithelia from the tongue dorsum of 14- to 21-day embryos, 21-day embryos, 3-week-old, and adult rats were separated from their connective tissues by incubation in balanced salt solution containing EDTA. Aliquots from total extracts of these tissues were electrophoresed on sodium dodecyl sulfate-polyacrylamide gels. Scans of gels stained with fast green (FG) revealed more than 20 peaks. Ten major peaks ranging from apparent molecular weights (MW) of 120,000 to 14,000 daltons comprised about 70% of the total protein on each gel. This report focuses primarily on two pairs of peaks, arbitrarily numbered 2 and 3 (MWs 71,000 and 69,000) and 9 and 10 (MWs 17,500 and 14,000). Peaks 9 and 10 predominated in the 15-day embryos where they comprised about 30% of the total protein. As development proceeded, there was a gradual shift in the protein profile in favor of peaks 2 and 3 until on the 20th day the relative amounts of these peaks reached a maximum and peaks 9 and 10 decreased in relative amounts. The protein profile on the 20th fetal day resembled that of the 3-week-old rats and the adults. The rise in the relative amounts of peaks 2 and 3 coincided with the morphologic appearance of large numbers of tonofilaments and the onset of cornification. When the gel was stained by a procedure specific for sulfhydryl groups, peaks 9 and 10 were especially reactive after the 18th day; plainmetric analysis revealed that these had twice the relative affinity for this stain than for FG whereas other peaks had equal or less affinity. The incorporation of [3H]cystine into peaks 9 and 10 was relatively greater than into the other proteins.
Asunto(s)
Proteínas/metabolismo , Lengua/metabolismo , Animales , Cistina/metabolismo , Electroforesis en Gel de Poliacrilamida , Epitelio/metabolismo , Feto/metabolismo , Peso Molecular , Reacción del Ácido Peryódico de Schiff , Ratas , Coloración y Etiquetado , Lengua/embriologíaRESUMEN
A simple and disposable holder for electron microscope grids can be constructed from discs of silicon rubber. The discs (10 mm thick X 25 mm diameter) are scored 0.4 mm deep with a razor. Flexing the discs opens the scores for insertion of grids. Staining wells can be made from polyethylene snap-in vial tops by cutting away the nipple-like portion. After impaling the holders on the tips of a pair of forceps the grids can be washed by immersion. This holder is rigid, inert and inexpensive. It is of particular advantage for handling single-slotted grids.